You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Association of bridging therapy utilization with clinical outcomes in patients receiving chimeric antigen receptor (CAR) T-cell therapy

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Association of bridging therapy utilization with clinical outcomes in patients receiving chimeric antigen receptor (CAR) T-cell therapy

 

Online download statistics by month:

Online download statistics by month: September 2022 to July 2025

AbstractFullPdf
Sep 202243143692
Oct 202214714852
Nov 202212314449
Dec 20229610515
Jan 202310010225
Feb 202311411525
Mar 2023818436
Apr 2023787927
May 2023626425
Jun 2023707115
Jul 2023828321
Aug 2023666724
Sep 202339415
Oct 2023545922
Nov 2023989916
Dec 2023353610
Jan 2024252613
Feb 2024293015
Mar 2024494947
Apr 2024424223
May 2024383923
Jun 2024323211
Jul 2024474920
Aug 2024414018
Sep 2024383817
Oct 2024727725
Nov 2024697220
Dec 2024495027
Jan 2025535518
Feb 202514614632
Mar 2025626322
Apr 2025868716
May 2025525215
Jun 2025484913
Jul 2025110
Total26552730834